Generic drug firms cry foul as Israel returns to U.S. blacklist

04.05.2011                      30.Nisan, 5771                      Rosch Hodesch 1; Tag 15 des Omer

Wirtschaft:

Generic drug firms cry foul as Israel returns to U.S. blacklist

Israel is on Washington's list of trading partners whose protections for intellectual property rights it considers inadequate largely because of Israel's failure to comply with benchmarks it agreed to in February 2010.

Israel was returned to Washington's list of trading partners whose protections for intellectual property rights it considers inadequate, issued yesterday. Other countries on the Office of the United States Trade Representative list include Russia, Algeria, Pakistan, China, Indonesia, India and Venezuela.
The designation was due in large measure to Israel's failure to comply with benchmarks it agreed to in February 2010. According to the understanding reached with U.S. trade officials, the Knesset was to pass legislation to amend its pharmaceutical regime in order to give greater protection to proprietary (as opposed to generic ) drugs….